Background on chemotherapy-induced peripheral neuropathy（CIPN）Incidence,prevalence,and consequences：Up to 90%of cancer patients experience CIPN at some point during or after anticancer treatment（Seretny et al.,201...Background on chemotherapy-induced peripheral neuropathy（CIPN）Incidence,prevalence,and consequences：Up to 90%of cancer patients experience CIPN at some point during or after anticancer treatment（Seretny et al.,2014）.展开更多
基金the National Cancer Institute[CA122298(MRK)]the National Institutes of Health,[R21NS091667(MRK and JCF)]+2 种基金the Earl and Betty Herr Professor in Pediatric Oncology Research,Jeff Gordon Children’s Foundationthe Riley Children’s Foundation(MRK)IU Simon Cancer Center Neurotoxicity Working Group(MRK and JCF)
文摘Background on chemotherapy-induced peripheral neuropathy（CIPN）Incidence,prevalence,and consequences：Up to 90%of cancer patients experience CIPN at some point during or after anticancer treatment（Seretny et al.,2014）.
